Touyun Biotech Group Limited (HKG:1332)
Hong Kong · Delayed Price · Currency is HKD 0.1580
-0.0010 (-0.63%)
Sep 4, 2026, 3:59 PM HKT
Touyun Biotech Group Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 70.92 | 66.97 | 99.6 | 198.64 | 315.83 | 283.51 |
Revenue Growth | 5.90% | -32.76% | -49.86% | -37.10% | 11.40% | 37.10% |
Gross Profit Gross Profit Growth | 15.69 | 16.22 | 38.7 | 53.88 | 120.12 | 107.05 |
Operating Income Operating Income Growth | -49.61 | -60.14 | -36.51 | -90.15 | -42.47 | -38.15 |
Net Income Net Income Growth | 213.4 | 26.8 | -88.11 | -268.94 | -198.07 | -72.95 |
Earnings Per Share EPS Growth | 0.08 | 0.01 | -0.03 | -0.10 | -0.07 | -0.03 |
EPS Growth | 699.39% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Packaging Products Packaging Products Growth | 60.19 | 62.28 | 75.85 | 106.91 | 211.34 | 172.46 |
Treasury Investment Treasury Investment Growth | 0.16 | -4.98 | 7.67 | 0.61 | -7.51 | -7.91 |
Chlamydomonas Reinhardtii Products Business Chlamydomonas Reinhardtii Products Business Growth | 10.56 | 9.67 | 16.09 | 20.32 | 12.62 | 1.32 |
Total Total Growth | 70.92 | 66.97 | 99.6 | 198.64 | 315.83 | 283.51 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4.39 | 7.58 | 73.51 | 43.56 | 150.45 | 99.87 |
Total Debt Total Debt Growth | 565.36 | 512.68 | 481.78 | 479.3 | 490.55 | 411.41 |
Net Cash (Debt) Net Cash Growth | -560.97 | -505.09 | -408.27 | -435.74 | -340.1 | -311.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.20 | -0.18 | -0.15 | -0.16 | -0.12 | -0.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | -29.64 | -49.98 | 2.18 | -26.37 | -53.81 |
Capital Expenditures CapEx Growth | - | -1.16 | -3.66 | -17.13 | -12.93 | -163.51 |
Free Cash Flow Free Cash Flow Growth | - | -30.8 | -53.64 | -14.95 | -39.3 | -217.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.12% | 24.22% | 38.86% | 27.12% | 38.03% | 37.76% |
Operating Margin | -69.95% | -89.81% | -36.66% | -45.38% | -13.45% | -13.46% |
Pretax Margin | 454.32% | 71.04% | -79.48% | -137.23% | -63.07% | -43.37% |
Profit Margin | 300.92% | 40.02% | -88.46% | -135.39% | -62.71% | -25.73% |
FCF Margin | - | -45.99% | -53.86% | -7.53% | -12.44% | -76.66% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2.33 | 26.70 | - | - | - | - |
PS Ratio | 6.29 | 10.68 | 5.24 | 3.25 | 3.82 | 13.07 |